In this context, we found that only 14% of individuals with late-stage MM showed a proportion of cytotoxic and immunosuppressive T lymphocytes in the BM that was predictive of an ICB response, which may provide a scientific explanation to the negative results in anti-PD-1 clinical trials15,16. Here, PDCD1 is linked to Miyoshi myopathy.